Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000528
Filing Date
2025-03-28
Accepted
2025-03-28 16:15:35
Documents
72
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ckpt-20241231x10k.htm   iXBRL 10-K 2207329
2 EX-4.6 ckpt-20241231xex4d6.htm EX-4.6 58388
3 EX-10.46 ckpt-20241231xex10d46.htm EX-10.46 64966
4 EX-19.1 ckpt-20241231xex19d1.htm EX-19.1 70999
5 EX-23.1 ckpt-20241231xex23d1.htm EX-23.1 3493
6 EX-31.1 ckpt-20241231xex31d1.htm EX-31.1 8134
7 EX-31.2 ckpt-20241231xex31d2.htm EX-31.2 8064
8 EX-32.1 ckpt-20241231xex32d1.htm EX-32.1 4498
9 EX-32.2 ckpt-20241231xex32d2.htm EX-32.2 4456
10 GRAPHIC ckpt-20241231x10k007.jpg GRAPHIC 3467
  Complete submission text file 0001410578-25-000528.txt   8812342

Data Files

Seq Description Document Type Size
11 EX-101.SCH ckpt-20241231.xsd EX-101.SCH 56733
12 EX-101.CAL ckpt-20241231_cal.xml EX-101.CAL 41424
13 EX-101.DEF ckpt-20241231_def.xml EX-101.DEF 252853
14 EX-101.LAB ckpt-20241231_lab.xml EX-101.LAB 475317
15 EX-101.PRE ckpt-20241231_pre.xml EX-101.PRE 380259
75 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20241231x10k_htm.xml XML 1159853
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

EIN.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38128 | Film No.: 25786471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)